GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Anesiva, Inc. (ANSVQ) [hlAlert]

Rating:
Mkt Outperform
ANSVQ
down 99.93 %

Anesiva, Inc. (ANSV) rated Mkt Outperform with price target $6 by Rodman & Renshaw

Posted on: Thursday,  Feb 21, 2008  8:25 AM ET by Rodman & Renshaw

Rodman & Renshaw rated Mkt Outperform Anesiva, Inc. (OTCBB: ANSVQ) on 02/21/2008, when the stock price was $4.43.
Since then, Anesiva, Inc. has lost 99.93% as of 01/10/2012's recent price of $0.00.
If you would have followed this Rodman & Renshaw's recommendation on ANSVQ, you would have lost 99.93% of your investment in 1419 days.

Anesiva, Inc. (Anesiva) is a biopharmaceutical company focused on the development and commercialization of therapeutic treatments for pain management. Its portfolio includes two products. Adlea, a long-acting, site-specific, non-opioid analgesic, is being developed for moderate to severe pain, and has completed multiple Phase II trials in post-surgical, musculoskeletal and neuropathic pain and Phase III trials in bunionectomy and total knee arthroplasty (TKA, or total knee replacement surgery). The Company is initially pursuing an indication for Adlea for the management of acute pain associated with orthopedic surgeries. Zingo (lidocaine hydrochloride monohydrate) powder intradermal injection system, was approved by the Food and Drug Administration (FDA) in August 2007, to reduce the pain associated with peripheral intravenous (IV) insertions or blood draws in children 3 to 18 years of age. Zingo was approved in January 2009, to reduce the pain associated with blood draws in adults.

Rodman & Renshaw is a full-service investment bank dedicated to providing investment banking services to companies that have significant recurring capital needs due to their growth and development strategies. We also provide research and sales and trading services to institutional investor clients that focus on such companies. Since 2003, Rodman has been a leading investment banking firm to the biotechnology sector, a capital intensive market segment, as well as a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/21/2008 8:25 AM Buy
None
4.43 6.00
as of 12/24/2008
1 Week down  -3.84 %
1 Month   
3 Months down  -50.00 %
1 YTD down  -28.57 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy